ClinicalTrials.gg
CompletedNCT06436014PainUpdated Nov 18, 2026

Evaluation of the Effect of Virtual Reality Application on Postoperative Pain and Anxiety in Women

An interventional study of Providing VR experience in Pain Management After Surgery, sponsored by Osmaniye Korkut Ata University. Completed at 2 sites in Turkey (Türkiye). Open to female participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Osmaniye Korkut Ata University · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 18, 2026Now CompletedFirst site in Turkey (Türkiye)+11 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,107 studies in Pain, Postoperative with a site in Turkey — 266 open to participants now, 300 under way, none of them phase 3. Pain, Postoperative · Turkey.

Enrollment
355th of 892
76 · median 70
Started
2025
with 169 others
No phase
823 of 1,107
220 open now
Registered
480th of 1,107
by date

Among the 1,107 studies in Pain, Postoperative with a site in Turkey, this one is the 355th largest by enrollment of the 892 interventional ones that give a count, is one of 170 that started in 2025, is one of 823 with no phase, and was the 480th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

266 of the 1,107 studies in Pain, Postoperative with a site in Turkey are open now. Recruiting first, the newest first:

261 more — sign in →

All 266 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 85 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,107 studies in Pain, Postoperative with a site in Turkey, or all of them as a file.
02

Study summary

Surgical interventions, while significant milestones in patients\' physical recovery processes, can be a major source of concern for patients due to postoperative pain, which is also an important component of postoperative care. If postoperative pain is not managed properly, it can lead to increased levels of anxiety and fear, as well as deterioration in overall comfort and quality of life. The ineffective management of postoperative pain has economic and medical consequences such as patient dissatisfaction, delayed hospital discharge, increased rates of hospital readmission, and dissatisfaction with medical care. Therefore, effective management of postoperative pain is of great importance for patient well-being. Factors associated with postoperative pain have been reported in many studies. For example, being female and the type of surgery. Therefore, considering gender and type of surgery in the management of postoperative pain is crucial to optimize the recovery process for patients. In recent years, research on the use of innovative technologies such as virtual reality in the management of postoperative pain has increased. Virtual reality can reduce postoperative pain by creating a sense of being in a different environment for patients and diverting their attention away from pain.

Read the detailed description

This randomized controlled trial evaluated the effects of virtual reality (VR) on postoperative pain, anxiety, physiological parameters, and analgesic use in women aged 18 years and older undergoing total knee arthroplasty (TKA) or cesarean section (CS) at Osmaniye State Hospital. The study also examined whether the effects of VR differed by surgery type.

Within each surgery category, eligible participants were assigned to VR or control groups using a lottery method performed by clinical nurses who were not members of the research team. Folded slips indicating VR or control allocation were drawn from a box, resulting in four groups: VR-TKA, control-TKA, VR-CS, and control-CS. Participants, the intervention provider, and the outcome assessor were aware of group allocation.

Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Pain and anxiety were assessed using separate 10-cm Visual Analog Scales (VAS). Physiological measurements included systolic and diastolic blood pressure, pulse rate, and peripheral oxygen saturation (SpO₂).

Participants in the VR groups received a 10-minute VR session in addition to routine postoperative care. They selected one of four relaxing nature videos featuring lake and river scenery, the sea and a tropical beach, morning nature scenes, or forest scenery. The device and planned intervention duration were standardized, while content selection reflected individual preferences. Videos were presented without headphones at the device's maximum volume. Control groups received routine postoperative care without VR. All assessments were repeated immediately after the 10-minute intervention or corresponding control period (T2). VR sessions and assessments were conducted with participants in a semi-sitting position in bed.

Analgesic use was obtained from patient records and medication administration charts. Video preferences, intervention completion, and participants' feedback regarding their VR experience were recorded. When participants reported dizziness, the video was stopped. Sixteen participants discontinued VR because of dizziness; the final analyses included 126 participants who completed the study: 36 in VR-TKA and 30 in each of the other three groups.Analgesic use was obtained from patient records and medication administration charts. Video preferences, intervention completion, participants' feedback regarding their VR experience, and the occurrence of dizziness during the VR session were recorded. When participants reported dizziness, the video was stopped, and their T2 assessments were performed at the time the headset was removed. Sixteen participants discontinued VR because of dizziness.

The primary analysis included all 142 randomized participants in the groups to which they were assigned (intention-to-treat), using analysis of covariance (ANCOVA) with the T2 score as the dependent variable, the T1 score as the covariate, and VR status and surgery type as fixed factors, including their interaction. Two sensitivity analyses were performed: a conservative analysis in which the T1 scores of participants who discontinued VR were carried forward as their T2 scores (n = 142), and a per-protocol analysis including only participants who completed the intervention (n = 126: 36 in VR-TKA and 30 in each of the other three groups). The primary models were also repeated with age as an additional covariate.

The study was initially approved by the Osmaniye Korkut Ata University Ethics Committee on November 29, 2023 (Decision No. 2023/8/3), and institutional permission was obtained from Osmaniye State Hospital on December 22, 2023. However, after the gynecologic surgeons left the hospital, hysterectomy procedures were no longer performed, and eligible hysterectomy patients could not be recruited. Therefore, the hysterectomy group was replaced with a cesarean section group, and a protocol amendment was approved by the ethics committee on March 2, 2026 (Decision No. 2026/3/2). Recruitment of cesarean section participants began after this amendment was approved.Data for the total knee arthroplasty groups were collected between January 2024 and December 2024 under the initial ethics approval. Data for the cesarean section groups were collected between March 2026 and November 2026, after the protocol amendment had been approved. Ethical approval was obtained from the Osmaniye Korkut Ata University Ethics Committee (Decision No. 2023/8/3, November 29, 2023), and institutional permission was obtained from Osmaniye State Hospital (December 22, 2023). A protocol amendment replacing the hysterectomy group with a cesarean section group was approved on March 2, 2026 (Decision No. 2026/3/2). Written informed consent was obtained from all participants, and the study was conducted in accordance with the Declaration of Helsinki.

03

Conditions studied

  • Pain Management After Surgery

Browse trials for

Keywords

  • Virtual Reality (VR)
  • Postoperative Pain
  • Pain Management Patient Experience
04

Who can participate

The criteria were revised on the registry on Nov 18, 2026. See what changed

Ages eligible
18 Years to 85 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being female and aged 18 years or older.
  • Having undergone total knee arthroplasty or cesarean section.
  • Being at postoperative hour 24.
  • Being conscious and able to communicate.
  • Being able to understand the assessment instruments.
  • Having no severe visual or hearing impairment or physical condition that would prevent the use of a VR headset.

Exclusion criteria

Exclusion Criteria:

  • Having severe cognitive or communication difficulties.
  • Experiencing deterioration in clinical condition.
  • Having a neurological or vestibular disorder.
  • Experiencing active nausea or vomiting.
  • Having an active eye infection.
  • Having wounds in the facial or head region that would interfere with VR headset use.

Withdrawal Criterion:

- Requesting withdrawal from the study.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
76 participants (actual)

Study arms

  • Experimental
    Total Knee Replacement VR Intervention Group

    Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They then received a 10-minute VR intervention in addition to routine postoperative care. All assessments were repeated immediately after the intervention (T2).

    Other: Providing VR experience

  • No intervention
    Total Knee Replacement Control Group

    Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They received routine postoperative care without VR. All assessments were repeated after the same 10-minute interval used in the VR group (T2).

  • Experimental
    Cesarean Section VR Intervention Group

    Pre-Test + Intervention + Post-Test) Participants who underwent cesarean section surgery and received a pre-test, followed by VR intervention.Participants in this group are initially assessed with a pre-test, followed by VR intervention.

    Other: Providing VR experience

  • No intervention
    Total Knee Group

    Participants who underwent total knee arthroplasty completed baseline assessments (T1) of pain and anxiety using separate 10-cm Visual Analog Scales (VAS), along with measurements of systolic and diastolic blood pressure, pulse rate, and SpO₂. They received routine postoperative care without VR. All assessments were repeated after the same 10-minute interval used in the VR group (T2).

Interventions

  • OtherProviding VR experience

    Participants undergoing VR intervention will experience a VR program of their choice based on personal preferences. Among these programs are videos offering natural visual experiences. For instance, participants can opt for videos featuring seaside views, forest tours, or lake landscapes.

06

What researchers measure

Primary outcomes

  1. The VR application is effective in changing postoperative pain.

    Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) in women aged 18 years and older undergoing total knee arthroplasty or cesarean section. Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Participants in the VR groups then received a 10-minute VR intervention alongside routine care, while control groups continued to receive routine care alone. Pain intensity was reassessed (T2) immediately after this 10-minute period in all groups.

    Time frame: The researcher's first visit to the patient on postoperative day 1.

Secondary outcomes

  1. The VR application is effective in changing postoperative anxiety.

    Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) in women aged 18 years and older undergoing total knee arthroplasty or cesarean section. Baseline assessments (T1) were performed at postoperative hour 24, 40 minutes after analgesic administration. Participants in the VR groups then received a 10-minute VR intervention alongside routine care, while control groups continued to receive routine care alone. Pain intensity was reassessed (T2) immediately after this 10-minute period in all groups.

    Time frame: The researcher's first visit to the patient on postoperative day 1.

07

Study locations

2 sites
  • Osmaniye Korkut Ata University
    Center, Osmani̇ye 80010, Turkey (Türkiye)
  • Osmaniye State Hospital
    Center, Osmani̇ye 80010, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2025 to primary completion in Nov 2026, 18 months.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 18 months is above that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: start Jul 2024 → Apr 2025, primary completion Jul 2025 → Nov 2026 and completion Jul 2025 → Nov 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 2, 2024
First posted
May 30, 2024
StartActual
Apr 15, 2025was Jul 2024
Primary completionActual
Nov 1, 2026was Jul 2025
CompletionActual
Nov 1, 2026was Jul 2025
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Nov 18, 2026
Sites
2 sites added, 2 sites removed — first site in Turkey (Türkiye); no longer in Turkey
Show 2 added (2 Turkey (Türkiye))
  • Osmaniye Korkut Ata University · Center, Turkey (Türkiye)
  • Osmaniye State Hospital · Center, Turkey (Türkiye)
Show 2 removed
  • Osmaniye Korkut Ata University · Merkez, Turkey
  • Osmaniye State Hospital · Merkez, Turkey
Nov 18, 2026
Start date
Jul 2024→Apr 15, 2025 (actual)
Nov 18, 2026
Primary completion
Jul 2025→Nov 1, 2026 (actual)
Nov 18, 2026
Study completion
Jul 2025→Nov 1, 2026 (actual)
Nov 18, 2026
Eligibility
Minimum age 50 Years→18 Years; Maximum age 70 Years→85 Years; Criteria largely rewritten (31 changes)
What changed in the criteria
Inclusion criteria
  • RemovedBeing between the ages of 50-70,
  • RemovedBeing female,
  • RemovedHaving adequate vision and hearing,
  • RemovedHaving American Society of Anesthesiologists (ASA) physical status classification I and II,
  • RemovedUndergoing elective total knee replacement or hysterectomy surgery,
  • RemovedHaving a similar analgesia protocol,
  • RemovedBeing on the first postoperative day,
  • RemovedScoring 5 or higher on the Visual Analogue Scale (VAS) assessment,
  • AddedBeing female and aged 18 years or older.
  • AddedHaving undergone total knee arthroplasty or cesarean section.
  • AddedBeing at postoperative hour 24.
  • AddedBeing conscious and able to communicate.
  • EditedBeing able to speak and understand Turkishthe assessment instruments.
  • AddedHaving no severe visual or hearing impairment or physical condition that would prevent the use of a VR headset.
Exclusion criteria
  • RemovedHaving chronic pain,
  • RemovedScoring below 5 on the Visual Analogue Scale (VAS) assessment,
  • RemovedExperiencing vertigo or motion-sensitive nausea,
  • RemovedBeing diagnosed with severe anxiety by a specialist physician,
  • RemovedHaving claustrophobia,
  • RemovedHaving head or neck conditions that prevent wearing virtual reality goggles,
  • RemovedHaving a Glasgow Coma Score \<15,
  • RemovedHaving psychiatric, cognitive, or neurological impairments,
  • RemovedHaving visual or hearing impairments.
  • AddedHaving severe cognitive or communication difficulties.
  • AddedExperiencing deterioration in clinical condition.
  • AddedHaving a neurological or vestibular disorder.
  • AddedExperiencing active nausea or vomiting.
  • AddedHaving an active eye infection.
  • AddedHaving wounds in the facial or head region that would interfere with VR headset use.
  • AddedWithdrawal Criterion:
  • Added- Requesting withdrawal from the study.
Nov 18, 2026
Interventions
Arm changed Hysterectomy VR Intervention Group→Cesarean Section VR Intervention Group. Arms added: Total Knee Group; arms removed: Hysterectomy Control Group
Nov 18, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionThe VR application is effective in changing postoperative pain.: how it is measured was reworded
Nov 18, 2026
Secondary outcomes
1 description edited
What changed in the outcomes
  • DescriptionThe VR application is effective in changing postoperative anxiety.: how it is measured was reworded
Nov 18, 2026
Title
Evaluation of the Effect of Virtual Reality Application on Postoperative Pain and Anxiety in Women Aged 50-70
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Not yet recruiting→Completed
    2 sites added, 2 sites removed — first site in Turkey (Türkiye); no longer in Turkey
    Show 2 added (2 Turkey (Türkiye))
    • Osmaniye Korkut Ata University · Center, Turkey (Türkiye)
    • Osmaniye State Hospital · Center, Turkey (Türkiye)
    Show 2 removed
    • Osmaniye Korkut Ata University · Merkez, Turkey
    • Osmaniye State Hospital · Merkez, Turkey
    Start date Jul 2024→Apr 15, 2025 (now actual)
    Primary completion Jul 2025→Nov 1, 2026 (now actual)
    Study completion Jul 2025→Nov 1, 2026 (now actual)
    Eligibility Minimum age 50 Years→18 Years; Maximum age 70 Years→85 Years; Criteria largely rewritten (31 changes)
    What changed in the criteria
    Inclusion criteria
    • RemovedBeing between the ages of 50-70,
    • RemovedBeing female,
    • RemovedHaving adequate vision and hearing,
    • RemovedHaving American Society of Anesthesiologists (ASA) physical status classification I and II,
    • RemovedUndergoing elective total knee replacement or hysterectomy surgery,
    • RemovedHaving a similar analgesia protocol,
    • RemovedBeing on the first postoperative day,
    • RemovedScoring 5 or higher on the Visual Analogue Scale (VAS) assessment,
    • AddedBeing female and aged 18 years or older.
    • AddedHaving undergone total knee arthroplasty or cesarean section.
    • AddedBeing at postoperative hour 24.
    • AddedBeing conscious and able to communicate.
    • EditedBeing able to speak and understand Turkishthe assessment instruments.
    • AddedHaving no severe visual or hearing impairment or physical condition that would prevent the use of a VR headset.
    Exclusion criteria
    • RemovedHaving chronic pain,
    • RemovedScoring below 5 on the Visual Analogue Scale (VAS) assessment,
    • RemovedExperiencing vertigo or motion-sensitive nausea,
    • RemovedBeing diagnosed with severe anxiety by a specialist physician,
    • RemovedHaving claustrophobia,
    • RemovedHaving head or neck conditions that prevent wearing virtual reality goggles,
    • RemovedHaving a Glasgow Coma Score \<15,
    • RemovedHaving psychiatric, cognitive, or neurological impairments,
    • RemovedHaving visual or hearing impairments.
    • AddedHaving severe cognitive or communication difficulties.
    • AddedExperiencing deterioration in clinical condition.
    • AddedHaving a neurological or vestibular disorder.
    • AddedExperiencing active nausea or vomiting.
    • AddedHaving an active eye infection.
    • AddedHaving wounds in the facial or head region that would interfere with VR headset use.
    • AddedWithdrawal Criterion:
    • Added- Requesting withdrawal from the study.
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionThe VR application is effective in changing postoperative pain.: how it is measured was reworded
    Secondary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionThe VR application is effective in changing postoperative anxiety.: how it is measured was reworded
    Interventions Arm changed Hysterectomy VR Intervention Group→Cesarean Section VR Intervention Group. Arms added: Total Knee Group; arms removed: Hysterectomy Control Group
    Title Evaluation of the Effect of Virtual Reality Application on Postoperative Pain and Anxiety in Women Aged 50-70
    + 5 other changes: verification date, description, design details, contact details and data sharing statement

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06436014
Lead sponsor
Osmaniye Korkut Ata University
Responsible party
Songul Gungor (Lecturer Phd, Osmaniye Korkut Ata University) — Principal investigator
First posted
May 30, 2024
Start date
Apr 15, 2025
Primary completion
Nov 1, 2026
Completion
Nov 1, 2026
Last update
Nov 18, 2026

Study contacts

Songül GÜNGÖR, Phd
principal investigator · Osmaniye Korkut Ata University
Ayşe TAŞTEKİN, associate professor
study director · Afyonkarahisar Health Sciences University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion